Results 221 to 230 of about 403,859 (288)

Correction to "Isocitrate Dehydrogenase 2 Mutation Promotes Cytarabine Resistance in Acute Myeloid Leukemia by Warburg Effect". [PDF]

Hematol Oncol
europepmc   +1 more source

Assessing the predictability of isocitrate dehydrogenase mutational status in glioma patients using imaging features. [PDF]

Surg Neurol Int
Goncalves JM, Miranda A, Silva C, Carvalho B, Polónia P, Linhares P.   +5 more
europepmc   +1 more source

Clinical and Prognostic Implications of Isocitrate Dehydrogenase Mutation in Gliomas Within a Latin American Public Oncology System: Insights From a Retrospective Panamanian Cohort. [PDF]

Cureus
Palma-García F, Abrego A, O Neill A, Lorenzo-Luaces R, Salgado M, Chong P, Castillo J, Arauz RE.   +7 more
europepmc   +1 more source

Study on the phosphorylation of NAD⁺-specific isocitrate dehydrogenase in the pathogenic bacteria <i>Stenotrophomonas maltophilia</i> and <i>Xanthomonas sacchari</i>. [PDF]

J Enzyme Inhib Med Chem
Tian Q, Zhang Y, Pan C, Wang L, Qin N, Jiang Z, Li C, Cao Z, Zhu G, Wang P.   +9 more
europepmc   +1 more source

<i>C. elegans</i> Cytoplasmic Isocitrate Dehydrogenase Neomorphic G98N and R133H Mutants Produce the Oncometabolite 2-Hydroxyglutarate. [PDF]

Int J Mol Sci
Bouchard M, McAllister A, Bourlett NS, Hoyt C, Calcul L, Walstrom KM.   +5 more
europepmc   +1 more source

Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma. [PDF]

Neuro Oncol
Sussman JH, Cillo AR, Kohli S, Cardello C, Patterson J, Akca E, Angione A, Moon D, Krueger K, Ghamari A, Xu E, Xu J, Tarbay AC, Li A, Budihal BR, Zhang X, Elghawy O, Panek WK, Rajappa P, Tan K, Vignali DAA, Bruno TC, Amankulor NM.   +22 more
europepmc   +1 more source

Isocitrate dehydrogenase-mutant astrocytoma in persons aged 55 years and older: Survival differences versus the young. [PDF]

J Neuropathol Exp Neurol
Siddiq Z, Gilani A, Ung TH, Kleinschmidt-DeMasters BK.   +3 more
europepmc   +1 more source

Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma. [PDF]

Oncologist
Xu S, Cao L, Chen R, Ye C, Li Q, Jiang Q, Yan F, Wan M, Zhang X, Ruan J.   +9 more
europepmc   +1 more source

The utility of multi-b-value diffusion and arterial spin labelling magnetic resonance imaging in gliomas grading and prediction of isocitrate dehydrogenase status. [PDF]

Quant Imaging Med Surg
Kopřivová T, Dostál M, Jůza T, Vybíhal V, Neuman E, Ovesná P, Kozubek M, Keřkovský M.   +7 more
europepmc   +1 more source

Metal coordination and enzymatic reaction of the glioma-target R132H isocitrate dehydrogenase 1: Insights by molecular simulations. [PDF]

PLoS One
Raghavan B, De Vivo M, Carloni P.
europepmc   +1 more source